Home NDC 36000-302 methocarbamol
Product NDC 36000-302
11-digit product format 360000302
Labeler code 36000
Product ID 36000-302_53ba7308-02bf-4520-ae39-5c69e17852c5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name methocarbamol
Dosage form INJECTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Baxter Healthcare Corporation
Application ANDA215065
Marketing category ANDA
Marketing start 2022-07-14
Substance METHOCARBAMOL
Active strength 100 mg/mL
Pharmacologic classes Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 4 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 36000-302-25 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 36000-302-25 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215065-001 METHOCARBAMOL METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV AP 2022-07-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV AP 2022-07-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV AP 2022-07-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV AP 2022-07-14 e64feba35796…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215065-001 METHOCARBAMOL 1GM/10ML (100MG/ML) SOLUTION / IM-IV 2022-07-14 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base methocarbamol
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength METHOCARBAMOL 100 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 125OD7737X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 238175 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 36000-302-01 methocarbamol 10 mL in 1 VIAL INJECTION 10 5 36000-302-25 methocarbamol 25 in 1 CARTON INJECTION 25 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 36000-302 METHOCARBAMOL INJECTION [BAXTER HEALTHCARE CORPORATION] 4 Current NDC, Legacy NDC, 2 package rows 20241101_a7f70b19-75ba-4e3d-b4fe-277fe7305bf0.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 36000-302-01 36000030201 10 mL in 1 VIAL 10 ml Historical 36000-302-25 36000030225 25 VIAL in 1 CARTON (36000-302-25) / 10 mL in 1 VIAL (36000-302-01) 25 vial 2022-07-14 0000-00-00 No No Current